{
    "clinical_study": {
        "@rank": "110805", 
        "arm_group": [
            {
                "arm_group_label": "Placebo Nasal filter", 
                "arm_group_type": "Sham Comparator", 
                "description": "Placebo treatment"
            }, 
            {
                "arm_group_label": "Nasal Filter", 
                "arm_group_type": "Active Comparator", 
                "description": "Active treatment"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the effect of reducing exposure to allergens in\n      patients with hay fever by means of a nasal filter."
        }, 
        "brief_title": "Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis (Hay Fever)", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Rhinitis, Allergic, Seasonal", 
        "condition_browse": {
            "mesh_term": [
                "Rhinitis, Allergic, Seasonal", 
                "Rhinitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  History of seasonal allergic rhinitis (SAR) for a minimum of 2 years before study\n             entry. Documented by a positive skin test within 12 months of study enrollment.\n\n          -  Written informed consent\n\n          -  Reliable anticonception for fertile women\n\n          -  Must be able to complete the study\n\n          -  Forced Expiratory Volume at one second (FEV1) higher than 70 % of predicted value\n\n          -  Positive grass immunoglobulin-E (IgE) blood sample equal to or higher than 3,50 kU/L\n\n        Exclusion Criteria:\n\n          -  Positive pregnancy test for fertile women\n\n          -  Asthma unless mild and only occurring in relation to the grass pollen season as\n             assessed by the investigator\n\n          -  Inadequate washout periods in regards to Environmental Exposure Unit (EEU)\n             appointments (intranasal or systemic corticosteroids (1month), intranasal cromolyn (2\n             weeks), intranasal or systemic decongestants (3 days), intranasal or systemic\n             antihistamines (3 days), loratadine (10 days))\n\n          -  Rhinitis medicamentosa\n\n          -  Use of long acting anti-histamines\n\n          -  Documented evidence of acute or chronic sinusitis as determined by individual\n             investigator\n\n          -  FEV1 lower than 70 % of predicted value\n\n          -  Subjects with perennial allergic rhinitis (PAR) to e.g. house dust mites, cats, dogs\n             moulds unless symptom free\n\n          -  Allergic rhinitis requiring medication caused by allergens other than grass unless\n             symptom free\n\n          -  Subjects with nasal conditions likely to affect the outcome of the study in the\n             opinion of the investigator, i.e. anterior nasal septum deviation, nasal septum\n             perforations, nasal polyps, chronic nasal obstruction or other nasal diseases\n\n          -  Receipt of immunotherapy with grass pollen within the previous 10 years\n\n          -  Women who are breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "24", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01699165", 
            "org_study_id": "1202-2", 
            "secondary_id": [
                "CIV-12-06-007121", 
                "1-10-72-371-12."
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Nasal Filter", 
                "description": "Active nasal filter", 
                "intervention_name": "Nasal filter", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Placebo Nasal filter", 
                "description": "Placebo nasal filter", 
                "intervention_name": "Placebo nasal filter", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "rhinitis", 
            "allergic", 
            "seasonal", 
            "double blind", 
            "doubleblind", 
            "randomized", 
            "randomised", 
            "placebo", 
            "crossover", 
            "clinical", 
            "nasal", 
            "filter", 
            "controlled", 
            "trial", 
            "hayfever", 
            "hay", 
            "fever", 
            "efficacy", 
            "safety", 
            "prevention", 
            "adult", 
            "grass", 
            "pollen", 
            "symptom", 
            "Total nasal symptom score", 
            "acoustic rhinometry"
        ], 
        "lastchanged_date": "April 18, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Aarhus", 
                    "country": "Denmark", 
                    "zip": "8200"
                }, 
                "name": "Aarhus University, School of Public Health, Department of Environmental & Occupational Medicine"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy and Safety of Nasal Filters on Seasonal Allergic Rhinitis in a Double-blinded Randomized Placebo-controlled Crossover Pilot Study", 
        "other_outcome": [
            {
                "description": "On each study day: pre-exposure and post exposure: 30 minutes post and 3 hours post", 
                "measure": "To assess symptoms using a VAS Scale symptoms questionnaire (PC)", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and Day 15"
            }, 
            {
                "description": "By means of a product evaluation questionnaire. On each study day evaluated 30 minutes post exposure", 
                "measure": "To assess the tolerability and safety of nasal filters", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1 and Day 15"
            }, 
            {
                "description": "On each study day: pre-exposure, 30 minutes post exposure and 3 hours post exposure", 
                "measure": "To assess the effects on the lower airway via nitrogen oxide measurements during expiration.", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1 and Day 15"
            }, 
            {
                "description": "On each study day: pre-exposure, 30 minute post exposure and in 3 hour intervals for 24 hours", 
                "measure": "Spirometric lung function", 
                "safety_issue": "Yes", 
                "time_frame": "Day 1 and Day 15"
            }, 
            {
                "description": "To assess the effects of active nasal filters on symptoms development in patients with seasonal allergic rhinitis (SAR) exposed to air-born allergens compared to the same patients in an exposed environment with a placebo nasal filter determined by their maximum Total Ocular Symptom Score (TOSS) out of the nine samples taken during a trial day. The statistical analysis will be done using non-parametric paired Wilcoxon signed rank test.", 
                "measure": "Effect of active nasal filters compared to placebo filters in the same patient group as measured by difference in maximum Total Ocular Symptom Score (TOSS)", 
                "safety_issue": "No", 
                "time_frame": "Day 1 and day 15"
            }
        ], 
        "overall_official": {
            "affiliation": "Aarhus University, School of Public Health, Dept. of Environmental & Occupational Medicine", 
            "last_name": "Torben Sigsgaard, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": [
                "Denmark: Danish Health and Medicines Authority", 
                "Denmark: Danish Dataprotection Agency", 
                "Denmark: The Regional Committee on Biomedical Research Ethics"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "To assess the effects of active nasal filters on symptoms development in patients with seasonal allergic rhinitis (SAR) exposed to air-born allergens compared to the same patients in an exposed environment with a placebo nasal filter determined by their maximum Total Nasal Symptom Score (TNSS) out of the nine samples taken during a trial day. The statistical analysis will be done using non-parametric paired Wilcoxon signed rank test.", 
            "measure": "Effect of active nasal filters compared to placebo filters in the same patient group as measured by difference in maximum Total Nasal Symptom Score", 
            "safety_issue": "No", 
            "time_frame": "Day 1 and day 15"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01699165"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "To assess the effects of active nasal filters on intranasal volume in patients with seasonal allergic rhinitis (SAR) exposed to air-born allergens compared to the same patients in an exposed environment with a placebo nasal filter. The assessment will be based on the difference between minimum and maximum volume as determined by acoustic rhinometry measurements pre- and post-exposure on each study day. The statistical analysis will be a parametric paired t-test.", 
            "measure": "Effect of active nasal filters compared to placebo filters as measured by acoustic rhinometry", 
            "safety_issue": "No", 
            "time_frame": "Day 1 and day 15"
        }, 
        "source": "University of Aarhus", 
        "sponsors": {
            "collaborator": {
                "agency": "Spirare ApS", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}